Rossari Biotech Limited
Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India.
What Rossari files
- Others55
- Important36
- Investor Meet32
- Board Meeting13
- Updates12
- PPTs9
Rossari Biotech reported Q1 FY27 consolidated revenue up 28% to Rs. 697.2 Cr, EBITDA up 19% to Rs. 80.6 Cr, and PAT up 4% to Rs. 35.1 Cr. The company established a new 5,000 MTPA blending facility in Thailand and completed the sale of its Andheri office, continuing non-core asset...
Company's board approved quarterly financial results. It granted 4,000 stock options at Rs 531 each and allotted 2,500 ESOP shares, increasing paid-up capital to Rs 11.08 Cr. An internal restructuring for ~Rs 24 Cr will streamline overseas subsidiaries under Rossari Singapore.
Rossari Biotech reports record Q4: Revenue up 18% to ₹684.9 Cr, PAT up 34% to ₹46.0 Cr. FY26 revenue at ₹2,396.4 Cr, PAT at ₹149.2 Cr. Company commissioned 15,000 MTPA ethoxylation capacity and a new R&D facility. Declared ₹0.50/share dividend.
Rossari Biotech reported Q3 revenue up 13% to Rs. 581.7 Cr and PAT up 3% to Rs. 32.8 Cr. The Board approved setting up greenfield specialty chemicals facilities in KSA, aiming to enhance supply chain resilience and accelerate speed-to-market.
Rossari Biotech's board approved Q3 & 9M results. Strategic move: greenfield specialty chemical plant in Saudi Arabia. Asset monetization: Kanjurmarg office sold for Rs. 25 Cr. Portfolio optimization: Bangladesh subsidiary closure approved, no operational impact.